Parabolic Drugs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for PARABDRUGS, BSE:533211 Parabolic Drugs Ltd.

11 Votes:
Buy 27.27%
Sell 54.55%
Hold 18.18%
BUY
SELL
HOLD